U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
12/31/2022 | 09/30/2022 | ||||
---|---|---|---|---|---|
Revenue | 40.85% | -42.04% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 40.85% | -42.04% | |||
Cost of Revenue | -7.55% | -14.52% | |||
Gross Profit | 67.78% | -50.82% | |||
SG&A Expenses | -4.02% | -10.52% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -4.04% | -10.62% | |||
Operating Income | 5.65% | 8.83% | |||
Income Before Tax | -0.21% | 0.82% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -0.21% | 0.82% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -0.21% | 0.82% | |||
EBIT | 5.65% | 8.83% | |||
EBITDA | -- | -- | |||
EPS Basic | 0.00% | 10.00% | |||
Normalized Basic EPS | 0.00% | 0.00% | |||
EPS Diluted | 0.00% | 10.00% | |||
Normalized Diluted EPS | 0.00% | 0.00% | |||
Average Basic Shares Outstanding | 4.18% | 2.02% | |||
Average Diluted Shares Outstanding | 4.18% | 2.02% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |